Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

4.170 -0.030 (-0.71%)

Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist

Price and Volume

Volume	4,207,200
Open	4.132
Bid (Size)	4.150 (100)
Ask (Size)	4.230 (500)
Prev. Close	4.200
Today's Range	4.090 - 4.420
52wk Range	2.960 - 40.37
Shares Outstanding	45,711,975
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CAPRICOR INVESTOR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. and Encourages Investors to Contact the Firm

Today 16:29 EDT

From Bragar Eagel & Squire

Via GlobeNewswire

Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws

Today 15:38 EDT

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Performance

YTD	-85.3%	-85.3%
1 Month	-81.4%	-81.4%
3 Month	-87.6%	-87.6%
6 Month	-81.9%	-81.9%
1 Year	-45.7%	-45.7%

More News

Deadline Alert: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Today 15:30 EDT

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Deadline Approaching: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith

Today 15:05 EDT

From Law Offices of Howard G. Smith

Via Business Wire

CAPRICOR THERAPEUTICS, INC. (CAPR) INVESTOR ALERT Investors With Large Losses in Capricor Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Today 12:47 EDT

From Bernstein Liebhard LLP

Via GlobeNewswire

Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors with Significant Losses to Contact the Firm Before September 28, 2026

Today 10:30 EDT

From Kaplan Fox & Kilsheimer, LLP

Via GlobeNewswire

Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm to Learn About Their Legal Rights

August 03, 2026

Via NewMediaWire

INVESTOR ALERT: Securities Class Action Filed Against Capricor Therapeutics, Inc. – Investors Encouraged to Contact Kirby McInerney LLP

August 03, 2026

From Kirby McInerney LLP

Via Business Wire

CAPR Class Action Lawsuit FILED: Capricor Therapeutics Sued for Securities Fraud after Stock Drops 64% Leading to Securities Fraud Case – Investors Urged to Contact BFA Law

August 03, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

Rosen Law Firm Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

August 03, 2026

From Rosen Law Firm

Via Business Wire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

Via Newsfile

Law Offices of Frank R. Cruz Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders To Inquire About Securities Fraud Class Action

August 03, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Deadline Soon: Capricor Therapeutics, Inc. (CAPR) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

August 03, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – CAPR

August 03, 2026

From DJS Law Group

Via Business Wire

CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law

August 01, 2026

From Schall, Brown & Schwartz LLP

Via Business Wire

Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit

July 31, 2026

From Robbins LLP

Via Business Wire

Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

The trading volume of these stocks is deviating from the norm in today's session. ↗

July 31, 2026

Via Chartmill

CAPR Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Capricor (CAPR)

July 31, 2026

From Levi & Korsinsky

Via Business Wire

Law Offices of Howard G. Smith Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders To Inquire About Securities Fraud Class Action

July 31, 2026

From Law Offices of Howard G. Smith

Via Business Wire

CAPR CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Capricor Therapeutics, Inc.

July 31, 2026

From The Law Offices of Frank R. Cruz

Via Business Wire

CAPR CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit on Behalf of Capricor Therapeutics, Inc.

July 30, 2026

From Glancy Prongay Wolke & Rotter LLP

Via Business Wire

Lowey Dannenberg, P.C. is Investigating Capricor Therapeutics, Inc. (NASDAQ: CAPR) for Potential Violations of the Federal Securities Laws

July 30, 2026

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Here are the top movers in Thursday's session. ↗

July 30, 2026

Via Chartmill

CAPR Stock Drop Alert: Capricor Therapeutics Stock Plummets Over 64% After FDA Briefing Documents Raise Concerns, Triggering Securities Fraud Investigation by BFA Law

July 30, 2026

From Bleichmar Fonti & Auld LLP

Via Business Wire

Frequently Asked Questions

Is Capricor Therapeutics, Inc. - Common Stock publicly traded?

Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?

Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?

The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market

What is the current price of Capricor Therapeutics, Inc. - Common Stock?

The current price of Capricor Therapeutics, Inc. - Common Stock is 4.170

When was Capricor Therapeutics, Inc. - Common Stock last traded?

The last trade of Capricor Therapeutics, Inc. - Common Stock was at 08/04/26 04:00 PM ET

What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?

The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 190.62M

How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?

Capricor Therapeutics, Inc. - Common Stock has 191M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.